Biovie (BIVI) Other financing activities (2020 - 2021)

Biovie (BIVI) posted Other financing activities of $516551.0 for Q3 2021, up 206.1% sequentially from $168751.0 in Q2 2021.

Biovie (BIVI) Other financing activities (2020 - 2021) Analysis & Trends

Biovie has reported Other financing activities for 2 years, with the latest figure at $516551.0 in Q3 2021.

Quarterly Other financing activities changed N/A year-over-year to $516551.0 in Q3 2021, while the trailing twelve-month figure through Mar 2025 was $516551.0 (changed N/A YoY) and the FY2023 annual result came in at $2240.0, changed N/A from the prior year.
Other financing activities rose to $516551.0 in Q3 2021 per BIVI's latest filing, from $168751.0 in the prior quarter.
Over five years, Other financing activities peaked at $516551.0 in Q1 2021 and troughed at $13487.0 in Q1 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Biovie	14.17 Mn	14.17 Mn	-

Download Data